Arvinas News and Activities

Presence

Arvinas is a biotechnology company focused on developing new small molecules ‎known as PROTACs (PROteolysis TArgeting Chimeras), aimed at degrading disease-causing cellular proteins. Target customers include healthcare providers and patients in the oncology and immuno-oncology sectors.

  • Oncology
  • Immuno-oncology

Employees: 200


Arvinas is one of the...

Arvinas is a company listed under the stock ticker ARVN (US).

Executives

View the org chart displaying its 37 main executives

Most searched biographies at Arvinas
Popular executive movements at Arvinas
  • John Northcott, Chief Commercial Officer, has left the company  (posted on January 22 2025).

Create your alert
to follow the executive moves at Arvinas.

Biotechnology

Arvinas has 2,340 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry

News

Press releases by Arvinas
Social media about Arvinas

Get in Touch

Call Arvinas at +1 203...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Customized Data Solutions
Executives
Companies
The Official Board